BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 27298346)

  • 1. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein.
    Galvagnion C; Brown JW; Ouberai MM; Flagmeier P; Vendruscolo M; Buell AK; Sparr E; Dobson CM
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7065-70. PubMed ID: 27298346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.
    Galvagnion C
    J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic aspects of Parkinson's disease: alpha-synuclein and the biomembrane.
    Beyer K
    Cell Biochem Biophys; 2007; 47(2):285-99. PubMed ID: 17652776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruptive membrane interactions of alpha-synuclein aggregates.
    Iyer A; Claessens MMAE
    Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):468-482. PubMed ID: 30315896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation.
    Flagmeier P; Meisl G; Vendruscolo M; Knowles TP; Dobson CM; Buell AK; Galvagnion C
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10328-33. PubMed ID: 27573854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adsorption of α-synuclein to supported lipid bilayers: positioning and role of electrostatics.
    Hellstrand E; Grey M; Ainalem ML; Ankner J; Forsyth VT; Fragneto G; Haertlein M; Dauvergne MT; Nilsson H; Brundin P; Linse S; Nylander T; Sparr E
    ACS Chem Neurosci; 2013 Oct; 4(10):1339-51. PubMed ID: 23823878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane Remodeling and Stimulation of Aggregation Following α-Synuclein Adsorption to Phosphotidylserine Vesicles.
    Hoover BM; Shen Z; Gahan CG; Lynn DM; Van Lehn RC; Murphy RM
    J Phys Chem B; 2021 Feb; 125(6):1582-1594. PubMed ID: 33538595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers.
    Fusco G; Chen SW; Williamson PTF; Cascella R; Perni M; Jarvis JA; Cecchi C; Vendruscolo M; Chiti F; Cremades N; Ying L; Dobson CM; De Simone A
    Science; 2017 Dec; 358(6369):1440-1443. PubMed ID: 29242346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of α-synuclein aggregation within liquid condensates.
    Dada ST; Toprakcioglu Z; Cali MP; Röntgen A; Hardenberg MC; Morris OM; Mrugalla LK; Knowles TPJ; Vendruscolo M
    Nat Commun; 2024 May; 15(1):3835. PubMed ID: 38714700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between α-synuclein amyloid formation and membrane structure.
    O'Leary EI; Lee JC
    Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):483-491. PubMed ID: 30287222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane Interactions of α-Synuclein Probed by Neutrons and Photons.
    Kaur U; Lee JC
    Acc Chem Res; 2021 Jan; 54(2):302-310. PubMed ID: 33415971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane interaction of α-synuclein in different aggregation states.
    Grey M; Linse S; Nilsson H; Brundin P; Sparr E
    J Parkinsons Dis; 2011; 1(4):359-71. PubMed ID: 23933657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease.
    van Rooijen BD; Claessens MM; Subramaniam V
    Curr Protein Pept Sci; 2010 Aug; 11(5):334-42. PubMed ID: 20423294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of α-synuclein oligomers with lipid membranes.
    Musteikytė G; Jayaram AK; Xu CK; Vendruscolo M; Krainer G; Knowles TPJ
    Biochim Biophys Acta Biomembr; 2021 Apr; 1863(4):183536. PubMed ID: 33373595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-vesicle imaging reveals lipid-selective and stepwise membrane disruption by monomeric α-synuclein.
    Hannestad JK; Rocha S; Agnarsson B; Zhdanov VP; Wittung-Stafshede P; Höök F
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14178-14186. PubMed ID: 32513706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminal Acetylation of α-Synuclein Changes the Affinity for Lipid Membranes but not the Structural Properties of the Bound State.
    Runfola M; De Simone A; Vendruscolo M; Dobson CM; Fusco G
    Sci Rep; 2020 Jan; 10(1):204. PubMed ID: 31937832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation.
    Galvagnion C; Buell AK; Meisl G; Michaels TC; Vendruscolo M; Knowles TP; Dobson CM
    Nat Chem Biol; 2015 Mar; 11(3):229-34. PubMed ID: 25643172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
    Sahay S; Ghosh D; Singh PK; Maji SK
    Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca(2+) modulating α-synuclein membrane transient interactions revealed by solution NMR spectroscopy.
    Zhang Z; Dai C; Bai J; Xu G; Liu M; Li C
    Biochim Biophys Acta; 2014 Mar; 1838(3):853-8. PubMed ID: 24316000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysics of α-synuclein induced membrane remodelling.
    Shi Z; Sachs JN; Rhoades E; Baumgart T
    Phys Chem Chem Phys; 2015 Jun; 17(24):15561-8. PubMed ID: 25665896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.